Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists.

Genes (Basel) · 2022 · PMC9601519 · PMID 36292636

Europe PMC DOI

hedged sentence

0.3190

closest p · 6.4× alpha

0.3190

boldest claim

The sentences

a decreasing trendp = 0.319not close (p > 0.1)

Müntze et al.: Lyso-Gb3 values showed a decreasing trend; median values declined from 10.4 (IQR 6.5–13.8) ng/mL to 6.1 (IQR 4.0–14.7) ng/mL ( p = 0.319) in the total patient cohort at the 1-year follow-up ( n = 14).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.